The UC San Diego analysis of over 17,000 Health and Retirement Study participants reveals women face steeper cognitive penalties from hypertension and elevated BMI than men, even when these factors occur at similar rates—an observational finding that highlights how biological sex modulates risk rather than simply prevalence. This pattern aligns with broader evidence from the 2020 Lancet Commission on dementia prevention, which identified 12 modifiable factors but treated them agnostically across sexes, overlooking how estrogen-related vascular changes and inflammatory responses may amplify cardiometabolic damage in women. A 2023 Neurology study on sex-stratified Alzheimer's cohorts further supports this by showing depression and sleep disruption compound faster in female brains, suggesting mainstream guidelines from the Alzheimer's Association still underweight these interactions. The original MedicalXpress coverage correctly notes prevalence gaps yet misses how observational designs like this one cannot isolate causation from reporting biases or unmeasured social determinants, while failing to connect findings to precision-medicine trials now testing sex-tailored interventions. Prioritizing impact over incidence could redirect resources toward earlier metabolic screening in midlife women, addressing a gap that current one-size-fits-all strategies continue to ignore.